About this medicine
- Approved name
- Yondelis
- International non-proprietary name (INN) or common name
- trabectedin
- Associated names
- Yondelis
- Class
- Antineoplastic agents
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/H/A-20/1493/C/0773/0060
- Type
- Article 20 procedures
This type of procedure is triggered for medicines that have been authorised via the centralised procedure in case of quality, safety or efficacy issues.
- Authorisation model
- Centrally authorised product(s)
Key dates and outcomes
- CHMP opinion date
- 24/07/2020
- EC decision date
- 24/09/2020